Skip to main content
. Author manuscript; available in PMC: 2010 Aug 3.
Published in final edited form as: Clin Cancer Res. 2007 Jun 1;13(11):3395–3402. doi: 10.1158/1078-0432.CCR-06-2441

Fig. 1.

Fig. 1

The effect of anginex and Avastin (bevacizumab) on global tumor pO2 over time. A, global tumor pO2 is transiently increased by anginex and Avastin in MA148, B16F10, and SCK tumors as measured by Eppendorf pO2 histograph. -■-, control; -●-, anginex; -▲-, Avastin. Points, average median pO2 value derived from, on average, 10 values per track, 4 tracks per mouse and 3 to 7 mice per treatment group per day (n = 120-700); bars, SE. B, typical pimonidazole stainings of control, anginex, and Avastin treatment of SCK tumors on days 2 and 7. Representative images of the means for the amount of staining across each section. Original magnification, ×200; bar, 50 μm. C, quantification of pimonidazole stainings of SCK tumors on days 2 and 7 by morphometric analysis. Following binarization of images, hypoxia was estimated by scoring the total number of white pixels per field. Columns, mean black pixel count per image; bars, SE.